Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 15/20 | 0.39 |
| ▸ | PPARG | P37231 | 13/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | ERN1 | O75460 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4148464 | 0.77 | PPARG (0.45) | PPARAPPARG | |
| SCHEMBL2384646 | 0.77 | TSHR (0.42) | XDH | |
| SCHEMBL27205115 | 0.75 | ALDH1A1 (0.46) | XDHERN1 | |
| SCHEMBL2569853 | 0.74 | ALDH1A1 (0.45) | PPARAPPARG | |
| SCHEMBL30497064 | 0.74 | LMNA (0.60) | XDHDRD2DRD4DRD1ERN1 | |
| SCHEMBL11768743 | 0.74 | LMNA (0.60) | XDHDRD2DRD4DRD1ERN1 | |
| SCHEMBL6255413 | 0.73 | SLC6A4 (0.41) | XDH | |
| SCHEMBL18244276 | 0.72 | HDAC3 (0.44) | — | |
| SCHEMBL3677399 | 0.72 | ALDH1A1 (0.59) | XDHERN1 | |
| SCHEMBL28009606 | 0.71 | ERN1 (0.49) | XDHERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2199273-B1 | Polymerizable photoinitiators and radiation curable compositions | AGFA NV (BE) | 2018-02-21 | — | — | EP | disclosed |
| US-8492452-B2 | Polymerizable photoinitiators and radiation curable compositions | AGFA GRAPHICS NV (BE) | 2013-07-23 | — | — | US | disclosed |
| US-20110224324-A1 | POLYMERIZABLE PHOTOINITIATORS AND RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-09-15 | — | — | US | disclosed |
| WO-2010069758-A1 | POLYMERIZABLE PHOTOINITIATORS AND RADIATION CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2010-06-24 | — | — | WO | disclosed |
| EP-2199273-A1 | Polymerizable photoinitiators and radiation curable compositions | AGFA Graphics NV (BE) | 2010-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224324-A1 | POLYMERIZABLE PHOTOINITIATORS AND RADIATION CURABLE COMPOSITIONS | WEE1, ZYX, MTR | XDH 1452/4885PPARA 1522/4885PPARG 1352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.